Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001412071-26-000006

President and CEO acquired 36,818 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Singh Shawn President and CEO 2026-06-30 Grant or award +36,818 $0.19 $7,073 54,846 D
Loading xslF345X06/form4-07022026_080729.xml…